Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-β1 can abrogate this resistance

American Journal of Pathology

Volumn 157, Issue 5, 2000, Pages 1661-1669

  Chodon, Thinle ^a   Sugihara, Tsuneki ^a   Igawa, Hiroharu H ^a   Funayama, Emi ^a   Furukawa, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; FAS ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERTROPHIC SCAR; KELOID; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033678547     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64803-1     Document Type: Article

References (58)

1. Keloids in various races
2. Keloids: A review
3. Excessive scarring as a consequence of healing
4. Clinical and biochemical features of normal, defective and pathologic scars
5. Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth
6. Serum-free keloid fibroblast cell culture: An in vitro model for the study of aberrant wound healing
7. Keloid fibroblasts exhibit an altered response to TGF-β
8. Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts
9. Effects of various growth factors and histamine on cultured keloid fibroblasts
10. The effect of TGF-β on keloid fibroblast proliferation and collagen synthesis
11. Effect of TGF-β on proliferative scar fibroblast cell Kinetics
12. Expression of transforming growth factor beta 1, 2, 3 proteins in keloids
13. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars
14. Increased proliferation in keloid fibroblasts wounded in vitro
15. Silver-stained nucleolar organizer regions in hypertrophic and keloid scars
16. p53 and apoptosis alterations in keloids and keloid fibroblasts
17. Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing Arch Dermatol
18. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar
19. The Fas death factor
20. Apoptosis signaling by death receptors
21. Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines
22. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor
23. Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts
24. Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: Differences between foreskin and adult fibroblasts
25. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
26. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor deprived hematopoietic cell lines
27. Effect of bcl-2 on Fas antigen-mediated cell death
28. Expression level of Bcl-2 determines anti- or proapoptotic function
29. Caspases: The executioners of apoptosis
30. Caspases: Killer proteases
31. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35
32. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase
33. Defective expression of hematopoietic protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis
34. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood
35. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis
36. Tamoxifen downregulates TGF-β production in keloid fibroblasts Ann Plast Surg
37. Role of growth factors in scar contraction: An in vitro analysis
38. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts
39. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor beta 1
40. Transforming growth factor-β inhibits apoptosis induced by β-amyloid peptide fragment 25-35 in cultured neuronal cells
41. TGF-beta 1 inhibition of apoptosis through the transcriptional up-regulation of BcL-X(L) in human monocytic leukemia U937 cells
42. Transforming growth factor-β inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc
43. Transforming growth factor beta 1 rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages
44. Transforming growth factor-β abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells
45. TGF-β1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis
46. Fas and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1
47. The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain
48. TGF-β2 activates proliferative scar fibroblasts
49. Anti-Fas on nonhematopoletic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness
50. Protease activation during apoptosis: Death by a thousand cuts?
51. Suicidal tendencies: Apoptotic cell death by caspase family proteinases
52. Mitochondria and apoptosis
53. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for pro-caspase-9 activation
54. Exogenous transforming growth factor beta (2) modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats
55. Use and specificity of staurosporine, UCN-01 and calphostin C as protein kinase inhibitors
56. TGF-β2 knockout mice have multiple developmental defects that are non-overlapping with other TGF-β knockout phenotypes
57. Role of transforming growth factor β in human disease
58. Hypertrophic scars, keloids and contractures. The cellular and molecular basis for therapy